Cargando…

Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort Study

BACKGROUND: For treating multidrug-resistant tuberculosis (MDR TB), the World Health Organization (WHO) recommends a regimen of at least four second-line drugs that are likely to be effective as well as pyrazinamide. WHO guidelines indicate only marginal benefit for regimens based directly on drug s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuen, Courtney M., Kurbatova, Ekaterina V., Tupasi, Thelma, Caoili, Janice Campos, Van Der Walt, Martie, Kvasnovsky, Charlotte, Yagui, Martin, Bayona, Jaime, Contreras, Carmen, Leimane, Vaira, Ershova, Julia, Via, Laura E., Kim, HeeJin, Akksilp, Somsak, Kazennyy, Boris Y., Volchenkov, Grigory V., Jou, Ruwen, Kliiman, Kai, Demikhova, Olga V., Vasilyeva, Irina A., Dalton, Tracy, Cegielski, J. Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700973/ https://www.ncbi.nlm.nih.gov/pubmed/26714320 http://dx.doi.org/10.1371/journal.pmed.1001932

Ejemplares similares

Additional Drug Resistance of Multidrug-Resistant Tuberculosis in Patients in 9 Countries
por: Kurbatova, Ekaterina V., et al.
Publicado: (2015)

Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia
por: Ershova, Julia V., et al.
Publicado: (2020)

Treatment Outcomes for Patients with Extensively Drug-Resistant Tuberculosis, KwaZulu-Natal and Eastern Cape Provinces, South Africa
por: Kvasnovsky, Charlotte L., et al.
Publicado: (2016)

Epidemiology of Primary Multidrug-Resistant Tuberculosis, Vladimir Region, Russia
por: Ershova, Julia V., et al.
Publicado: (2015)

Multidrug-resistant Tuberculosis Management in Resource-limited Settings
por: Nathanson, Eva, et al.
Publicado: (2006)

Multidrug-Resistant TB in the Philippines: Authors' Reply
por: Tupasi, Thelma
Publicado: (2006)

Prevalence of Anti-Tuberculosis Drug Resistance in Foreign-Born Tuberculosis Cases in the U.S. and in Their Countries of Origin
por: Taylor, Allison B., et al.
Publicado: (2012)

Association between Mycobacterium tuberculosis Complex Phylogenetic Lineage and Acquired Drug Resistance
por: Yuen, Courtney M., et al.
Publicado: (2013)

Reducing Communication Delays and Improving Quality of Care with a Tuberculosis Laboratory Information System in Resource Poor Environments: A Cluster Randomized Controlled Trial
por: Blaya, Joaquín A., et al.
Publicado: (2014)

Risk Factors for Acquisition of Drug Resistance during Multidrug-Resistant Tuberculosis Treatment, Arkhangelsk Oblast, Russia, 2005–2010
por: Smith, Sarah E., et al.
Publicado: (2015)

Tuberculosis Research in Taiwan
por: Jou, Ruwen
Publicado: (2011)

Targeted Drug-Resistance Testing Strategy for Multidrug-Resistant Tuberculosis Detection, Lima, Peru, 2005–2008
por: Velásquez, Gustavo E., et al.
Publicado: (2011)

Effectiveness of Favipiravir monotherapy in the treatment of COVID-19: real world data analysis from Thailand
por: Srisubat, Attasit, et al.
Publicado: (2023)

Factors Associated with Loss to Follow-up during Treatment for Multidrug-Resistant Tuberculosis, the Philippines, 2012–2014
por: Tupasi, Thelma E., et al.
Publicado: (2016)

Challenges and Controversies in Defining Totally Drug-Resistant Tuberculosis
por: Cegielski, Peter, et al.
Publicado: (2012)

The Tuberculosis-Depression Syndemic and Evolution of Pharmaceutical Therapeutics: From Ancient Times to the Future
por: Van Der Walt, Martie, et al.
Publicado: (2021)

Cities on the Coast and Patterns of Movement between Population Growth and Diffusion
por: Kovalevsky, Dmitry V., et al.
Publicado: (2021)

Tuberculosis Case Fatality and Other Causes of Death among Multidrug-Resistant Tuberculosis Patients in a High HIV Prevalence Setting, 2000-2008, South Africa
por: van der Walt, Martie, et al.
Publicado: (2016)

Human Tuberculosis Caused by Mycobacterium bovis, Taiwan
por: Jou, Ruwen, et al.
Publicado: (2008)

Extensively Drug-Resistant Tuberculosis,Taiwan
por: Yu, Ming-Chih, et al.
Publicado: (2008)

Tokyo-172 BCG Vaccination Complications, Taiwan
por: Jou, Ruwen, et al.
Publicado: (2009)

Performance of an Xpert-based diagnostic algorithm for the rapid detection of drug-resistant tuberculosis among high-risk populations in a low-incidence setting
por: Chiang, Ting-Yi, et al.
Publicado: (2018)

A web-based laboratory information system to improve quality of care of tuberculosis patients in Peru: functional requirements, implementation and usage statistics
por: Blaya, Joaquin A, et al.
Publicado: (2007)

Scale-up of Multidrug-Resistant Tuberculosis Laboratory Services, Peru
por: Shin, Sonya S., et al.
Publicado: (2008)

The relationship of the carriership of allelic variations in rs2228145 (A > C) of the IL6R gene with the levels of VCAM1 and ICAM1 gene transcripts in patients with essential hypertension
por: Topchieva, L.V., et al.
Publicado: (2020)

Developing health policies in patients presenting with SARS-CoV-2: consider tuberculosis
por: Keddy, Karen H, et al.
Publicado: (2020)

Multidrug-resistant Tuberculosis Detection, Latvia
por: Skenders, Girts, et al.
Publicado: (2005)

The value of effective public tuberculosis treatment: an analysis of opportunity costs associated with multidrug resistant tuberculosis in Latvia
por: Miller, Thaddeus L, et al.
Publicado: (2013)

Social Stigma and Knowledge of Tuberculosis and HIV among Patients with Both Diseases in Thailand
por: Jittimanee, Sirinapha X., et al.
Publicado: (2009)

Drug-resistant Mycobacterium tuberculosis, Taiwan
por: Jou, Ruwen, et al.
Publicado: (2006)

Laboratory Investigation of a Nosocomial Transmission of Tuberculosis at a District General Hospital
por: Huang, Wei-Lun, et al.
Publicado: (2007)

Decreased Time to Treatment Initiation for Multidrug-Resistant Tuberculosis Patients after Use of Xpert MTB/RIF Test, Latvia
por: Stagg, Helen R., et al.
Publicado: (2016)

Beyond new chemical entities: Advancing drug development based on functional versatility of antibodies
por: Caoili, Salvador Eugenio C, et al.
Publicado: (2014)

Survival under uncertainty: an introduction to probability models of social structure and evolution
por: Volchenkov, Dimitri
Publicado: (2016)

Nonlinear dynamics, chaos, and complexity: in memory of professor Valentin Afraimovich
por: Volchenkov, Dimitri
Publicado: (2021)

Memories of the Future. Predictable and Unpredictable Information in Fractional Flipping a Biased Coin
por: Volchenkov, Dimitri
Publicado: (2019)

Infinite Ergodic Walks in Finite Connected Undirected Graphs †
por: Volchenkov, Dimitri
Publicado: (2021)

Assessing Pandemic Uncertainty on Conditions of Vaccination and Self-isolation
por: Volchenkov, D.
Publicado: (2022)

Impact of HIV on mortality among patients treated for tuberculosis in Lima, Peru: a prospective cohort study
por: Velásquez, Gustavo E., et al.
Publicado: (2016)

Primary Bedaquiline Resistance Among Cases of Drug-Resistant Tuberculosis in Taiwan
por: Wu, Sheng-Han, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tj1sk8ns2aebv7e3b06dkphqjn